Mar 31, 2026 04:20PM eXoZymes Provides Fourth Quarter and Full Year 2025 Update

Mar 18, 2026 09:10AM Successful Pilot Scale Run with Cayman Chemical Validates eXoZymes' Technology and Scalability

Mar 12, 2026 04:15PM eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium

Feb 10, 2026 04:24PM eXoZymes launches redesigned website, narrows focus to pharmaceuticals

Feb 10, 2026 04:20PM With Refreshed Brand eXoZymes Sharpens Pharmaceutical Focus to Drive Platform Leverage and Long-Term Value Creation

Jan 29, 2026 07:45PM eXoZymes Advancing Commercial Readiness With Profound Production Metrics on Initial NCT Pilot Run

Jan 16, 2026 03:58PM Exozymes (EXOZ) files $50M mixed shelf

Dec 11, 2025 04:10PM eXoZymes scales NCT production 100-fold with 99% conversion rate

Dec 11, 2025 04:10PM eXoZymes Achieves 100× Scale-up of NCT Production Using Exozymes, Demonstrating Near-perfect Feedstock Conversion

Nov 13, 2025 04:30PM eXoZymes Provides Third Quarter 2025 Update at 5PM EST Today

Nov 13, 2025 04:15PM eXoZymes names Tyler Korman CSO and Amy Lunzer chief of staff

Nov 13, 2025 04:15PM eXoZymes Announces Cell-Free Biomanufacturing Pioneer, Tyler Korman, As CSO & Amy Lunzer as Chief of Staff

Nov 10, 2025 05:00PM eXoZymes to Host Third Quarter 2025 Update on Thursday November 13, 2025, at 5PM EST

Oct 30, 2025 04:10PM CEO of eXoZymes on 'AI in Life Sciences' panel at the Beryl Elites' Investment Conference

Oct 29, 2025 05:40PM CEO of eXoZymes to Present at Spartan Capital Securities' Second Annual Investor Conference

Oct 23, 2025 04:50PM CEO of eXoZymes to Present at ThinkEquity's Annual Investor Conference

Sep 30, 2025 04:10PM Driving the Cell-Free Revolution: eXoZymes Leaders Join BioMADE Leadership & Technical Committees

Aug 12, 2025 04:50PM eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today

Aug 7, 2025 06:35PM eXoZymes to Host Second Quarter 2025 Update on Tuesday August 12, 2025, at 5PM EST

Jul 29, 2025 07:57AM eXoZymes produces 4 grams of NCT compound with 99% purity

Jul 29, 2025 07:57AM eXoZymes Details Biomanufacturing Breakthrough: 4 Grams of NCT with Over 99% Purity

Jul 22, 2025 04:11PM eXoZymes achieves gram-scale NCT production in 5 months

Jul 22, 2025 04:10PM eXoZymes Biomanufacturing Breakthrough: From Concept to Gram-Scale NCT in Only 5 Months

Jun 26, 2025 04:10PM eXoZymes Selected as Core Industry Partner in $9M NSF-Funded Initiative to Advance Modular Cell-Free Biomanufacturing

May 16, 2025 09:25AM eXoZymes Highlights Scalable Biomanufacturing Platform and First Spinout, NCTx, on Grow Everything Podcast

May 12, 2025 04:10PM eXoZymes Provides First Quarter 2025 and NCTx Subsidiary Update at 5PM EST Today

May 7, 2025 05:20PM eXoZymes to Host First Quarter 2025 and Subsidiary NCTx Update on Monday May 12, 2025, at 5PM EST

May 6, 2025 04:10PM eXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver Health

Apr 14, 2025 05:00PM New to The Street's FOX Business "Late Night T.V." Special Airs Tonight – Show #650 – Featuring Health In Tech CEO Julia Qian (NASDAQ:HIT), BioVie's Dr. Joseph Palumbo (NASDAQ:BIVI), eXoZymes Co-F

Apr 2, 2025 04:10PM eXoZymes (EXOZ) appoints Damien Perriman as CCO

Mar 3, 2025 08:40PM New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With C

Feb 21, 2025 04:07PM eXoZymes (EXOZ) and MDB Capital (MDBH) Announce Leadership Transition at eXoZymes